Hungry? The drug purchase service has covered 93% of the urban area of Shanghai, with a cumulative distribution of more than 2.2 million orders

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Insilico Medicine (英矽智能) Signs Strategic Drug Discovery Partnership with Takeda (武田制药), Deal Worth Up to US$600 Million

Chinese AI drug discovery company Insilico Medicine (英矽智能) has signed a global strategic collaboration with Japanese pharmaceutical company Takeda (武田制药), with the total potential deal value reaching up to US$600 million. Announced in early July, the agreement marks another milestone in the international commercialization of China's AI-powered drug discovery technologies through collaboration with a leading multinational pharmaceutical company.

Drug Farm Raises $55 Million in First Closing of Series D Financing

According to EO (亿欧), Drug Farm (药物牧场) announced on July 13 that it had raised $55 million in the first closing of its Series D financing round.

EqualOcean Releases 2026 Chinese GoGlobal HealthTech Brands Top 10 at GGF2026

SHANGHAI, June 11, 2026 — EqualOcean officially released its 2026 Chinese GoGlobal HealthTech Brands Top 10 during the GoGlobal Forum of 100 2026 (GGF2026), one of China’s leading annual forums dedicated to globalization and international business expansion.

Meituan and Ele.me Lose Lawsuits Due to Unfair Competition, Catering Businesses Benefit

On April 14, the Huaian People's Court of Jiangsu Province made a judgment that Beijing Sankuai Technology Co., Ltd. (Meituan) should compensate CNY 352,000 to Shanghai Lazasi Information Technology Co., Ltd. (Ele.me). Meanwhile, Ele.me was also ordered to pay fines to Meituan for the same reason.